(Q43142282)

English

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome

scientific article published on 4 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 November 2017

Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome (English)

1 reference

Europe PubMed Central

14 November 2017

Karin Milde-Langosch

2

object named as

Karin Milde-Langosch

1 reference

Europe PubMed Central

14 November 2017

author name string

Isabell D Witzel

1

1 reference

Europe PubMed Central

14 November 2017

Ralph M Wirtz

3

1 reference

Europe PubMed Central

14 November 2017

Claudia Roth

4

1 reference

Europe PubMed Central

14 November 2017

Maike Ihnen

5

1 reference

Europe PubMed Central

14 November 2017

Sven Mahner

6

1 reference

Europe PubMed Central

14 November 2017

Christine Zu Eulenburg

7

1 reference

Europe PubMed Central

14 November 2017

Fritz Jänicke

8

1 reference

Europe PubMed Central

14 November 2017

Volkmar Müller

9

1 reference

Europe PubMed Central

14 November 2017

publication date

4 March 2010

1 reference

Europe PubMed Central

14 November 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

14 November 2017

136

1 reference

Europe PubMed Central

14 November 2017

11

1 reference

Europe PubMed Central

14 November 2017

1709-1718

1 reference

Europe PubMed Central

14 November 2017

https://scigraph.springernature.com/pub.10.1007/s00432-010-0829-4

0 references

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-010-0829-4

21 January 2018

Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Commercialized multigene predictors of clinical outcome for breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional and posttranscriptional regulation of the plasminogen activator system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapies in breast cancer: where are we now?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative real-time PCR analysis and microarray-based RNA expression of HER2 in relation to outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer patients and its association with tissue PAI-1 levels and tumor severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling of breast cancer: a new tumor marker

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative Assessment of HER-2/Neu Protein Concentration in Breast Cancer by Enzyme-Linked Immunosorbent Assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424).

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HER2 and the coamplified genes GRB7 and MLN64 in human breast cancer: quantitative real-time reverse transcription-PCR as a diagnostic alternative to immunohistochemistry and fluorescence in situ hybridization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20204407

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-010-0829-4

1 reference

Europe PubMed Central

14 November 2017

1 reference

Europe PubMed Central

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43142282&oldid=1981568435"